Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 03:35PM ET
17.87
Dollar change
+0.25
Percentage change
1.42
%
Index- P/E- EPS (ttm)-0.35 Insider Own31.76% Shs Outstand159.85M Perf Week1.42%
Market Cap2.86B Forward P/E34.52 EPS next Y0.52 Insider Trans-0.04% Shs Float109.08M Perf Month5.24%
Income-55.36M PEG- EPS next Q0.10 Inst Own68.78% Short Float4.84% Perf Quarter-1.05%
Sales354.34M P/S8.06 EPS this Y0.88% Inst Trans-1.86% Short Ratio10.05 Perf Half Y27.28%
Book/sh6.55 P/B2.73 EPS next Y19.34% ROA-3.53% Short Interest5.28M Perf Year-24.92%
Cash/sh1.47 P/C12.16 EPS next 5Y33.70% ROE-5.21% 52W Range11.81 - 24.96 Perf YTD1.59%
Dividend Est.- P/FCF35.27 EPS past 5Y-10.50% ROI-4.12% 52W High-28.41% Beta1.63
Dividend TTM- Quick Ratio2.62 Sales past 5Y21.37% Gross Margin47.35% 52W Low51.31% ATR (14)0.67
Dividend Ex-Date- Current Ratio2.62 EPS Y/Y TTM-471.37% Oper. Margin3.97% RSI (14)50.44 Volatility2.95% 3.98%
Employees1391 Debt/Eq0.28 Sales Y/Y TTM5.57% Profit Margin-15.62% Recom2.60 Target Price19.31
Option/ShortYes / Yes LT Debt/Eq0.28 EPS Q/Q-235.59% Payout0.00% Rel Volume0.84 Prev Close17.62
Sales Surprise1.53% EPS Surprise-17.81% Sales Q/Q1.59% EarningsFeb 29 AMC Avg Volume524.80K Price17.87
SMA20-2.29% SMA502.80% SMA2009.54% Trades Volume414,146 Change1.42%
Date Action Analyst Rating Change Price Target Change
Feb-26-24Initiated Leerink Partners Market Perform $19
Dec-07-23Initiated UBS Neutral $17
Dec-05-23Initiated KeyBanc Capital Markets Sector Weight
Aug-22-23Downgrade Jefferies Buy → Hold $24.50 → $17
Aug-10-23Downgrade William Blair Outperform → Mkt Perform
Apr-12-23Initiated Stephens Overweight $28
Apr-03-23Downgrade Barclays Overweight → Equal Weight $25
Dec-14-22Downgrade Robert W. Baird Outperform → Neutral $17 → $19
Sep-08-22Initiated Berenberg Buy $23
Aug-25-22Initiated Credit Suisse Outperform $22
Mar-02-24 08:41AM
Mar-01-24 07:10AM
Feb-29-24 06:05PM
04:52PM
04:10PM
04:30PM Loading…
Feb-01-24 04:30PM
Jan-31-24 11:03PM
Dec-13-23 04:30PM
Nov-21-23 04:30PM
Nov-10-23 01:22PM
Nov-09-23 10:41AM
Nov-08-23 07:15PM
04:10PM
Oct-31-23 12:00PM
Oct-20-23 08:34AM
04:15PM Loading…
Oct-11-23 04:15PM
Sep-19-23 08:15AM
Sep-13-23 05:01AM
Aug-29-23 04:15PM
08:15AM
Aug-23-23 01:43PM
Aug-22-23 02:41AM
Aug-12-23 08:07AM
Aug-11-23 06:09AM
Aug-10-23 09:41AM
Aug-09-23 04:15PM
Aug-03-23 09:00PM
Aug-02-23 08:55AM
Jul-27-23 09:47AM
Jul-13-23 04:30PM
04:15PM Loading…
Jun-02-23 04:15PM
May-16-23 06:50AM
May-09-23 06:53AM
May-08-23 06:35PM
04:15PM
May-02-23 10:02AM
04:24AM
May-01-23 02:03PM
10:01AM
07:13AM
Apr-28-23 07:15AM
Apr-27-23 08:00AM
Apr-10-23 04:30PM
Apr-06-23 12:19PM
Apr-05-23 12:25PM
11:42AM
Apr-04-23 12:43PM
Mar-29-23 12:01PM
Mar-28-23 03:00PM
Mar-27-23 11:35AM
Mar-15-23 05:41PM
10:00AM
Mar-14-23 09:40AM
Mar-09-23 12:20PM
08:00AM
Mar-08-23 07:04AM
Mar-07-23 08:00AM
Mar-02-23 07:43AM
Mar-01-23 06:25PM
04:16PM
04:15PM
Feb-27-23 04:30PM
Feb-01-23 04:30PM
Jan-09-23 11:40AM
Jan-04-23 07:31AM
Dec-23-22 06:35PM
Dec-08-22 04:30PM
Nov-26-22 09:01PM
Nov-11-22 04:28PM
Nov-07-22 07:05PM
04:15PM
08:00AM
Nov-02-22 05:00PM
Oct-19-22 08:00AM
Oct-13-22 07:45AM
Aug-31-22 08:00AM
Aug-11-22 04:38PM
Aug-09-22 09:00PM
07:45PM
05:00PM
04:15PM
Aug-05-22 08:00AM
Aug-01-22 03:02PM
Jul-28-22 08:00AM
Jul-25-22 08:00AM
Jul-13-22 08:00AM
Jul-12-22 08:00AM
Jul-09-22 02:05PM
Jun-28-22 08:00AM
Jun-21-22 08:00AM
May-05-22 09:31PM
06:55PM
04:15PM
May-03-22 04:30PM
Apr-20-22 08:00AM
Mar-24-22 09:29AM
Mar-17-22 09:36AM
Mar-01-22 09:30PM
06:45PM
04:15PM
Certara, Inc. engages in the provision of software and technology-enabled services for drug developers. It offers cell and gene therapy, clinical pharmacology, complex biologics, decision analytics and modeling, drug development and regulatory strategy, and model-based analysis services. The company was founded on June 27, 2017, and is headquartered in Princeton, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Traynor Richard M.SVP AND GENERAL COUNSELMar 04 '24Sale18.283,00054,840162,368Mar 05 04:45 PM
SMITH PATRICK FPRESIDENT, DRUG DEV SOLUTIONSFeb 20 '24Sale18.005,00090,00054,975Feb 21 04:40 PM
Traynor Richard M.SVP AND GENERAL COUNSELFeb 12 '24Sale18.006,000108,000165,368Feb 14 04:33 PM
Traynor Richard M.SVP AND GENERAL COUNSELDec 26 '23Sale18.006,000108,000171,368Dec 27 06:36 PM
Pedersen Leif EPRESIDENT, CHIEF COMMERCAL OFFSep 11 '23Sale14.6051,224747,870128,883Sep 12 04:26 PM
BROSHY ERANDirectorAug 22 '23Buy15.804,80775,95114,360Aug 23 04:38 PM
BROSHY ERANDirectorAug 21 '23Buy16.101933,1079,553Aug 23 04:38 PM
SMITH PATRICK FPRESIDENT, INTEGRATED DRUG DEVJun 05 '23Sale21.5519,104411,69159,975Jun 06 04:56 PM
BROSHY ERANDirectorMay 23 '23Option Exercise0.009,36009,360May 25 08:50 AM
Crane Rosemary ADirectorMay 23 '23Option Exercise0.009,32409,324May 25 08:45 AM
CASHMAN JAMES E IIIDirectorMay 17 '23Option Exercise0.009,0670447,849May 18 04:35 PM
Killefer NancyDirectorMay 17 '23Option Exercise0.009,067015,498May 18 04:47 PM
WALSH MATTHEW MDirectorMay 17 '23Option Exercise0.009,0670176,968May 19 08:36 AM
Collins CynthiaDirectorMay 17 '23Option Exercise0.009,067015,498May 19 08:34 AM
Traynor Richard M.SVP AND GENERAL COUNSELMay 11 '23Sale20.825,000104,100177,368May 15 04:41 PM
Traynor Richard M.SVP AND GENERAL COUNSELApr 14 '23Sale23.665,000118,300182,368Apr 17 05:07 PM
Virkler DraytonPRESIDENT, REG & ACCESMar 31 '23Option Exercise0.003,990013,581Apr 03 05:44 PM
Traynor Richard M.SVP AND GENERAL COUNSELMar 31 '23Option Exercise0.006,6510189,492Apr 03 04:49 PM
Pedersen Leif EPRESIDENT, SOFTWAREMar 31 '23Option Exercise0.008,6460182,213Apr 03 04:44 PM
Aspbury RobertPRESIDENT, SIMCYPMar 31 '23Option Exercise0.008,6460280,991Apr 03 04:42 PM
Feehery William FCHIEF EXECUTIVE OFFICERMar 31 '23Option Exercise0.0036,58002,195,285Apr 03 04:35 PM
SHERMAN NICOLETTE DCHIEF HUMAN RESOURCES OFFICERMar 31 '23Option Exercise0.003,990016,798Apr 03 04:53 PM
SMITH PATRICK FPRESIDENT, INTEGRATED DRUG DEVMar 31 '23Option Exercise0.008,646081,973Apr 03 04:51 PM
Schemick Michael AndrewCHIEF FINANCIAL OFFICERMar 31 '23Option Exercise0.0013,3020527,451Apr 03 04:40 PM